Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $48.46 USD
Change Today +0.10 / 0.21%
Volume 889.2K
IPXL On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michael J. Nestor

President of Impax Pharmaceuticals, Impax Laboratories Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

61$2,176,489
As of Fiscal Year 2014

Background*

Mr. Michael J. Nestor has been President of Impax Pharmaceuticals at Impax Laboratories Inc. since April 2008. Mr. Nestor served as Chief Operating Officer for Piedmont Pharmaceuticals in Greensboro, North Carolina. Mr. Nestor served as Chief Executive Officer and President of NanoBio Corporation. He served as the President, U.S. Branded Pharmaceuticals of Alpharma Inc. since February 2003. Mr. Nestor has almost 30 years of pharmaceutical company experience of increasing ...

Read Full Background

Corporate Headquarters*

30831 Huntwood Avenue
Hayward, California 94544

United States

Phone: 510-476-2000
Fax: 510-240-6096

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MBA
Pepperdine University

Other Affiliations*

Annual Compensation*

Salary$515,479
Total Annual Compensation$515,479

Stock Options*

Restricted Stock Awards$580,520
All Other Compensation$29,845
Exercisable Options193,625
Exercisable Options Value$3,366,401
Unexercisable Options118,375
Unexercisable Options Value$1,093,429
Total Value of Options$4,459,830
Total Number of Options312,000

Total Compensation*

Total Annual Cash Compensation$1,011,869
Total Short Term Compensation$515,479
Other Long Term Compensation$610,365
Total Calculated Compensation$2,176,489
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IPXL:US $48.46 USD +0.10

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMPAX LABORATORIES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.